Skip to main content
Clinical Trials/IRCT20221203056698N1
IRCT20221203056698N1Not yet recruitingPhase 2

Comparison of the effectiveness of combination gel (diltigel2%-ureacolchicine) with diltigel 2% in the treatment of acute anal fissures

Tabriz University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 75 years (—)
Sex
All

Inclusion Criteria

  • Age over 18 years
  • Consent to participate in the study
  • Suffering from acute anal fissure as diagnosed by a specialist doctor

Exclusion Criteria

  • Receiving chemotherapy drugs
  • Being under radiotherapy
  • History of Fisher and hemorrhoid surgery
  • Receiving medicine and herbal gel for the treatment of fissure
  • Receiving Diltigel before entering the study
  • Receiving lidocaine and tetracycline before entering the study
  • Having gout
  • History of uncontrolled blood pressure
  • Allergy to the drugs used in this study

Investigators

Similar Trials